发明名称 |
NOP RECEPTOR AGONISTS FOR THE TREATMENT OF L-DOPA INDUCED DYSKINESIAS |
摘要 |
The present invention relates to the chronic treatment with L,3-4-dihydroxyphenylalanine (L-DOPA). Chronic L-DOPA administration still represents the most effective pharmacological therapy of Parkinson's disease (PD) although it is invariably associated with the appearance (within 5-10 years after start of the therapy, in about 80 % of patients) of motor complications that limit its clinical effectiveness and greatly reduce the quality of life of patients (Obeso et al., 2000). These motor complications encompass motor fluctuations (e.g. wearing off and "on-off fluctuations) and abnormal involuntary movements or dyskinesias (peak dose and diphasic dyskinesias, dystonia). We report for the first time that in an animal model of dyskinesias, administration of agonists at nociceptin/orphanin FQ receptors, termed NOP receptors, dramatically reduces abnormal involuntary movements induced by L-DOPA administration. NOP receptor agonists thus represent a novel class of drugs useful for the treatment of L-DOPA induced dyskinesias. |
申请公布号 |
WO2008062296(A3) |
申请公布日期 |
2008.10.23 |
申请号 |
WO2007IB03597 |
申请日期 |
2007.11.23 |
申请人 |
UNIVERSITA' DEGLI STUDI DI FERRARA;MORARI, MICHELE;MARTI, MATTEO |
发明人 |
MORARI, MICHELE;MARTI, MATTEO |
分类号 |
A61K38/10;A61K31/438;A61K31/451;A61K31/454;A61K31/4706;A61P25/16 |
主分类号 |
A61K38/10 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|